{"count": 15, "results": [{"_id": "36794961", "pmid": 36794961, "title": "Impacts of Statin Therapy Strategies on Incidence of Ischemic Cerebrovascular Events in Patients With Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Bayesian Network Meta-Analysis.", "journal": "Neurosurgery", "authors": ["Zhong S", "Liu T", "Zhai Q", "Zhang X", "Jing H", "Li K", "Liu S", "Liu G", "Wang L", "Li L", "Tao S", "Ren L", "Shi X", "Bao Y"], "date": "2023-02-16T00:00:00Z", "doi": "10.1227/neu.0000000000002392", "meta_date_publication": "2023 Feb 16", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50245.98, "text_hl": "@CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@Pravastatin@@@ (40 mg/d) decreased the incidence @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@ICEs@@@ compared with placebo (RR, 0.14; 95% CI, 0.03-0.65) and was ranked the most effective, presenting with a significantly lower rate of the incidence @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@ICEs@@@ than the worst-ranked @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (40 mg/d) (RR, 0.13; 95% CI, 0.02-0.79). ", "citations": {"NLM": "Zhong S, Liu T, Zhai Q, Zhang X, Jing H, Li K, Liu S, Liu G, Wang L, Li L, Tao S, Ren L, Shi X, Bao Y. Impacts of Statin Therapy Strategies on Incidence of Ischemic Cerebrovascular Events in Patients With Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Bayesian Network Meta-Analysis. Neurosurgery. 2023 Feb 16;():. PMID: 36794961", "BibTeX": "@article{36794961, title={Impacts of Statin Therapy Strategies on Incidence of Ischemic Cerebrovascular Events in Patients With Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Bayesian Network Meta-Analysis.}, author={Zhong S and Liu T and Zhai Q and Zhang X and Jing H and Li K and Liu S and Liu G and Wang L and Li L and Tao S and Ren L and Shi X and Bao Y}, journal={Neurosurgery}}"}}, {"_id": "20644009", "pmid": 20644009, "title": "Simvastatin ameliorates rat cerebrovascular remodeling during hypertension via inhibition of volume-regulated chloride channel.", "journal": "Hypertension", "authors": ["Liu YJ", "Wang XG", "Tang YB", "Chen JH", "Lv XF", "Zhou JG", "Guan YY"], "date": "2010-09-01T00:00:00Z", "doi": "10.1161/HYPERTENSIONAHA.110.150102", "meta_date_publication": "2010 Sep", "meta_volume": "56", "meta_issue": "3", "meta_pages": "445-52", "score": 50066.12, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ ameliorates @SPECIES_10116 @@@rat@@@ @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular remodeling@@@ during @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ via inhibition of volume-regulated chloride channel.", "citations": {"NLM": "Liu YJ, Wang XG, Tang YB, Chen JH, Lv XF, Zhou JG, Guan YY. Simvastatin ameliorates rat cerebrovascular remodeling during hypertension via inhibition of volume-regulated chloride channel. Hypertension. 2010 Sep;56(3):445-52. PMID: 20644009", "BibTeX": "@article{20644009, title={Simvastatin ameliorates rat cerebrovascular remodeling during hypertension via inhibition of volume-regulated chloride channel.}, author={Liu YJ and Wang XG and Tang YB and Chen JH and Lv XF and Zhou JG and Guan YY}, journal={Hypertension}, volume={56}, number={3}, pages={445-52}}"}}, {"_id": "25564230", "pmid": 25564230, "title": "Simvastatin restored vascular reactivity, endothelial function and reduced string vessel pathology in a mouse model of cerebrovascular disease.", "journal": "J Cereb Blood Flow Metab", "authors": ["Tong XK", "Hamel E"], "date": "2015-03-01T00:00:00Z", "doi": "10.1038/jcbfm.2014.226", "meta_date_publication": "2015 Mar", "meta_volume": "35", "meta_issue": "3", "meta_pages": "512-20", "score": 50065.03, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ restored vascular reactivity, endothelial function and reduced string vessel pathology in a @SPECIES_10090 @@@mouse@@@ model of @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular disease@@@.", "citations": {"NLM": "Tong XK, Hamel E. Simvastatin restored vascular reactivity, endothelial function and reduced string vessel pathology in a mouse model of cerebrovascular disease. J Cereb Blood Flow Metab. 2015 Mar;35(3):512-20. PMID: 25564230", "BibTeX": "@article{25564230, title={Simvastatin restored vascular reactivity, endothelial function and reduced string vessel pathology in a mouse model of cerebrovascular disease.}, author={Tong XK and Hamel E}, journal={J Cereb Blood Flow Metab}, volume={35}, number={3}, pages={512-20}}"}}, {"_id": "21477202", "pmid": 21477202, "title": "A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.", "journal": "Br J Haematol", "authors": ["Hoppe C", "Kuypers F", "Larkin S", "Hagar W", "Vichinsky E", "Styles L"], "date": "2011-06-01T00:00:00Z", "doi": "10.1111/j.1365-2141.2010.08480.x", "meta_date_publication": "2011 Jun", "meta_volume": "153", "meta_issue": "5", "meta_pages": "655-63", "score": 50064.277, "text_hl": "A pilot study of the short-term use of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @DISEASE_Anemia_Sickle_Cell @DISEASE_MESH:D000755 @@@sickle cell disease@@@: effects on markers of @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@vascular dysfunction@@@.", "citations": {"NLM": "Hoppe C, Kuypers F, Larkin S, Hagar W, Vichinsky E, Styles L. A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol. 2011 Jun;153(5):655-63. PMID: 21477202", "BibTeX": "@article{21477202, title={A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction.}, author={Hoppe C and Kuypers F and Larkin S and Hagar W and Vichinsky E and Styles L}, journal={Br J Haematol}, volume={153}, number={5}, pages={655-63}}"}}, {"_id": "18509252", "pmid": 18509252, "title": "Effects of HMG-CoA reductase inhibition by simvastatin on vascular dysfunction induced by lipopolysaccharide in rats.", "journal": "Pharmacology", "authors": ["Alvarez de Sotomayor M", "Vega S", "Mingorance C", "Marhuenda E", "Herrera MD"], "date": "2008-01-01T00:00:00Z", "doi": "10.1159/000135629", "meta_date_publication": "2008", "meta_volume": "82", "meta_issue": "2", "meta_pages": "89-96", "score": 50062.03, "text_hl": "Effects of @GENE_HMGCR @GENE_25675 @@@HMG-CoA reductase@@@ inhibition by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@vascular dysfunction@@@ induced by @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@lipopolysaccharide@@@ in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Alvarez de Sotomayor M, Vega S, Mingorance C, Marhuenda E, Herrera MD. Effects of HMG-CoA reductase inhibition by simvastatin on vascular dysfunction induced by lipopolysaccharide in rats. Pharmacology. 2008;82(2):89-96. PMID: 18509252", "BibTeX": "@article{18509252, title={Effects of HMG-CoA reductase inhibition by simvastatin on vascular dysfunction induced by lipopolysaccharide in rats.}, author={Alvarez de Sotomayor M and Vega S and Mingorance C and Marhuenda E and Herrera MD}, journal={Pharmacology}, volume={82}, number={2}, pages={89-96}}"}}, {"_id": "30066928", "pmid": 30066928, "pmcid": "PMC6102662", "title": "Simvastatin improves cerebrovascular injury caused by ischemia-reperfusion through NF-kappaB-mediated apoptosis via MyD88/TRIF signaling", "journal": "Mol Med Rep", "authors": ["Chen Z", "Xiang Y", "Bao B", "Wu X", "Xia Z", "You J", "Nie H"], "date": "2018-09-01T00:00:00Z", "doi": "10.3892/mmr.2018.9337", "meta_date_publication": "2018 Sep", "meta_volume": "18", "meta_issue": "3", "meta_pages": "3177-3184", "score": 50060.008, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ may be a potential therapeutic agent for the treatment of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular injury@@@. ", "citations": {"NLM": "Chen Z, Xiang Y, Bao B, Wu X, Xia Z, You J, Nie H. Simvastatin improves cerebrovascular injury caused by ischemia-reperfusion through NF-kappaB-mediated apoptosis via MyD88/TRIF signaling Mol Med Rep. 2018 Sep;18(3):3177-3184. PMID: 30066928", "BibTeX": "@article{30066928, title={Simvastatin improves cerebrovascular injury caused by ischemia-reperfusion through NF-kappaB-mediated apoptosis via MyD88/TRIF signaling}, author={Chen Z and Xiang Y and Bao B and Wu X and Xia Z and You J and Nie H}, journal={Mol Med Rep}, volume={18}, number={3}, pages={3177-3184}}"}}, {"_id": "15016485", "pmid": 15016485, "title": "Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.", "journal": "Lancet", "authors": ["Collins R", "Armitage J", "Parish S", "Sleight P", "Peto R", "Heart Protection Study Collaborative Group"], "date": "2004-03-06T00:00:00Z", "doi": "10.1016/S0140-6736(04)15690-0", "meta_date_publication": "2004 Mar 6", "meta_volume": "363", "meta_issue": "9411", "meta_pages": "757-67", "score": 50057.52, "text_hl": "Effects of @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@-lowering with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@ and other major vascular events in 20536 people with @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular disease@@@ or other high-risk conditions.", "citations": {"NLM": "Collins R, Armitage J, Parish S, Sleight P, Peto R, Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004 Mar 6;363(9411):757-67. PMID: 15016485", "BibTeX": "@article{15016485, title={Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.}, author={Collins R and Armitage J and Parish S and Sleight P and Peto R and Heart Protection Study Collaborative Group}, journal={Lancet}, volume={363}, number={9411}, pages={757-67}}"}}, {"_id": "16127179", "pmid": 16127179, "title": "Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT).", "journal": "Circ J", "authors": ["Nakaya N", "Kita T", "Mabuchi H", "Matsuzaki M", "Matsuzawa Y", "Oikawa S", "Saito Y", "Sasaki J", "Shimamoto K", "Itakura H", "J-LIT Study Group"], "date": "2005-09-01T00:00:00Z", "doi": "10.1253/circj.69.1016", "meta_date_publication": "2005 Sep", "meta_volume": "69", "meta_issue": "9", "meta_pages": "1016-21", "score": 50055.68, "text_hl": "METHODS AND RESULTS: @SPECIES_9606 @@@Patients@@@ were treated with 5-10 mg/day of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and all, including those who discontinued @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ for any reason, had their @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ concentrations and incidence of @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@CVD@@@ monitored for 6 years. ", "citations": {"NLM": "Nakaya N, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, J-LIT Study Group. Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT). Circ J. 2005 Sep;69(9):1016-21. PMID: 16127179", "BibTeX": "@article{16127179, title={Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT).}, author={Nakaya N and Kita T and Mabuchi H and Matsuzaki M and Matsuzawa Y and Oikawa S and Saito Y and Sasaki J and Shimamoto K and Itakura H and J-LIT Study Group}, journal={Circ J}, volume={69}, number={9}, pages={1016-21}}"}}, {"_id": "19524673", "pmid": 19524673, "title": "Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.", "journal": "Neurobiol Dis", "authors": ["Tong XK", "Nicolakakis N", "Fernandes P", "Ongali B", "Brouillette J", "Quirion R", "Hamel E"], "date": "2009-09-01T00:00:00Z", "doi": "10.1016/j.nbd.2009.06.003", "meta_date_publication": "2009 Sep", "meta_volume": "35", "meta_issue": "3", "meta_pages": "406-14", "score": 50054.953, "text_hl": "Using 10 month-old @GENE_APP @GENE_11820 @@@amyloid precursor protein@@@ transgenic @SPECIES_10090 @@@mice@@@ (APP @SPECIES_10090 @@@mice@@@), we sought to reverse @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular, neuronal and memory impairments@@@ with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (20 mg/kg/day, 8 weeks). ", "citations": {"NLM": "Tong XK, Nicolakakis N, Fernandes P, Ongali B, Brouillette J, Quirion R, Hamel E. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiol Dis. 2009 Sep;35(3):406-14. PMID: 19524673", "BibTeX": "@article{19524673, title={Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.}, author={Tong XK and Nicolakakis N and Fernandes P and Ongali B and Brouillette J and Quirion R and Hamel E}, journal={Neurobiol Dis}, volume={35}, number={3}, pages={406-14}}"}}, {"_id": "28919704", "pmid": 28919704, "pmcid": "PMC5587089", "title": "Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis", "journal": "Drug Des Devel Ther", "authors": ["Zhong P", "Wu D", "Ye X", "Wu Y", "Li T", "Tong S", "Liu X"], "date": "2017-08-30T00:00:00Z", "doi": "10.2147/DDDT.S135785", "meta_date_publication": "2017", "meta_volume": "11", "meta_issue": "", "meta_pages": "2517-2526", "score": 50052.055, "text_hl": "A study indirectly compared influence of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on the @<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@cerebrovascular events@@@ (@<m>DISEASE_Cerebrovascular_Disorders</m> @DISEASE_MESH:D002561 @@@CVEs@@@), but it was a placebo-control study with a small sample size and there were active comparator trials in this study. ", "citations": {"NLM": "Zhong P, Wu D, Ye X, Wu Y, Li T, Tong S, Liu X. Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis Drug Des Devel Ther. 2017;11():2517-2526. PMID: 28919704", "BibTeX": "@article{28919704, title={Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis}, author={Zhong P and Wu D and Ye X and Wu Y and Li T and Tong S and Liu X}, journal={Drug Des Devel Ther}, volume={11}, pages={2517-2526}}"}}]}